Disclosures - A. Sanyal: Consultant; Current; Eli Lilly and Company, Abbott, GENFIT, Corcept Therapeutics, Arrowhead Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Genentech, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Lipocine Inc., Madrigal Pharmaceuticals, Inc., Merck & Co., Inc., GlaxoSmithKline plc., Novartis AG, Novo Nordisk, Pfizer Inc., Salix Pharmaceuticals, Sequana Medical NV, Takeda Pharmaceutical Company Limited. Other - Institution has received grant support; Current; AstraZeneca. Consultant; Current; AstraZeneca. Other - Institution has received grant support; Current; Bristol-Myers Squibb Company. Consultant; Current; Bristol-Myers Squibb Company. Other - Institution has received grant support; Current; Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Novartis AG. Other - Royalties; Current; Elsevier, UpToDate. Stock/Shareholder; Current; DURECT Corporation. M. Rinella: Consultant; Current; 89bio, Inc., Lilly, Novo Nordisk, Madrigal Pharmaceuticals, Inc., Regeneron Pharmaceuticals Inc., GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Altimmune, Akero Therapeutics, Inc.. Other - this is an error. cannot remove. Also could not add Akero and Echosens to disclosures; Current; Gan & Lee Pharmaceuticals. D. Chan: Employee; Current; Akero Therapeutics, Inc. S.K. Billes: Employee; Current; Akero Therapeutics, a Novo Nordisk Company. Stock/Shareholder; Current; Novo Nordisk. A. Zari: Employee; Current; Akero Therapeutics, Inc. T. Rolph: Employee; Current; Akero Therapeutics, Inc.. Stock/Shareholder; Current; Bioage. M. Noureddin: Advisory Panel; Current; Akero Therapeutics, a Novo Nordisk company, Altimmune, Alligos, AstraZeneca, Biogen, Boston Pharmaceuticals, Curve bioscience, Daiichi Sankyo, GlaxoSmithKline plc., HistoIndex, Kriya Therapeutics, Lilly, Madrigal Pharmaceuticals, Inc., Merck & Co., Inc., Neuraly Inc., Novo Nordisk, OPKO Health, Rivus, Sagimet, Takeda Pharmaceutical Company Limited. Research Support; Current; Allergan, Altimmune, Akero Therapeutics, a Novo Nordisk company, Biogen, Bristol-Myers Squibb Company, Boston Pharmaceuticals, Conatus, Corcept Therapeutics, Gilead Sciences, Inc., Galectin, GENFIT, GlaxoSmithKline plc., Kowa Pharmaceuticals America, Inc., Enanta, Madrigal Pharmaceuticals, Inc., Lilly, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Rivus, Shire plc., Takeda Pharmaceutical Company Limited, Terns, Viking Therapeutics, Zydus. Stock/Shareholder; Current; OPKO Health, Kriya Therapeutics, Akero Therapeutics, Inc.. Speaker's Bureau; Current; Madrigal Pharmaceuticals, Inc., Novo Nordisk.

Mary Rinella

University of Chicago

Appearances